All Phenotypes Rdh10<tm1c(KOMP)Wtsi> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1d(KOMP)Wtsi}	involves: 129S4/SvJae * C57BL/6N * FVB/NJ	MGI:7382902
cn2	Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi}	involves: 129S4/SvJae * C57BL/6N * FVB/NJ	MGI:7382903
cn3	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Amh-cre)8815Reb/0 Tg(RARE-Hspa1b/lacZ)12Jrt/0 Tg(Stra8-icre)1Reb/0	involves: C57BL/6 * C57BL/6N * CD-1 * FVB/N * SJL	MGI:5475537
cn4	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Stra8-icre)1Reb/0	involves: C57BL/6 * C57BL/6N * FVB/NJ * SJL	MGI:5475535
cn5	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Amh-cre)8815Reb/0	involves: C57BL/6 * C57BL/6N * FVB/N * SJL	MGI:5475534
cn6	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Amh-cre)8815Reb/0 Tg(Stra8-icre)1Reb/0	involves: C57BL/6 * C57BL/6N * FVB/N * SJL	MGI:5475536

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

craniofacial

craniofacial phenotype ( J:278485 )

N	• following tamoxifen treatment at E8.5 at E16.5 mandible size is not significantly different from controls, indicating this does not contribute to cleft palate

abnormal hyoid bone morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 variable morphological defects are seen

• in some cases the hyoid primordium is ectopically fused to the laryngeal prominence of the thyroid cartilage and the hyoid primordium has a gentle M shape

decreased palatine bone horizontal plate size ( J:278485 )

• feathery medial growth is lacking and ossified palatine bones do not approach the midline in 50% of embryos at E16.5 following tamoxifen treatment at E8.5

palatal shelves fail to meet at midline ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 in 40% of embryos the palatal shelves have elevated but fail to grow to the midline

• however, in maxillary explant cultures shelves elevate and make medial contact at a similar rate to controls

cleft secondary palate ( J:278485 )

• at E16.5 in 36% of embryos following tamoxifen treatment at E8.5

abnormal palatal shelf elevation ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 only 33% of mutant embryos have both shelves elevated compared to 82% of controls

• following tamoxifen treatment at E8.5 at E14.5 palatal shelves appear to be obstructed by the arched tongue at the posterior end of the shelves

abnormal tongue muscle morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 tongue muscles lack apparent attachment to the hyoid primordium

abnormal tongue position ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 the tongue is arched to the posterior rather than relatively flat as in controls

decreased tongue size ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 tongue volume is slightly reduced compared to controls

• however, no defects in intrinsic muscle morphology are seen

skeleton

abnormal hyoid bone morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 variable morphological defects are seen

• in some cases the hyoid primordium is ectopically fused to the laryngeal prominence of the thyroid cartilage and the hyoid primordium has a gentle M shape

decreased palatine bone horizontal plate size ( J:278485 )

• feathery medial growth is lacking and ossified palatine bones do not approach the midline in 50% of embryos at E16.5 following tamoxifen treatment at E8.5

abnormal cricoid cartilage morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 variable morphological defects are seen

abnormal thyroid cartilage morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 variable morphological defects are seen

• in some cases the hyoid primordium is ectopically fused to the laryngeal prominence of the thyroid cartilage

nervous system

abnormal motor neuron morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E11.5 the C1 motor nerve fuses directly to the CN XII nerve in 50% of embryos but never seen in controls

abnormal hypoglossal nerve morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E11.5 the C1 motor nerve fuses directly to the CN XII nerve in 50% of embryos but never seen in controls

respiratory system

abnormal cricoid cartilage morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 variable morphological defects are seen

abnormal thyroid cartilage morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 variable morphological defects are seen

• in some cases the hyoid primordium is ectopically fused to the laryngeal prominence of the thyroid cartilage

muscle

abnormal tongue muscle morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 tongue muscles lack apparent attachment to the hyoid primordium

digestive/alimentary system

decreased palatine bone horizontal plate size ( J:278485 )

• feathery medial growth is lacking and ossified palatine bones do not approach the midline in 50% of embryos at E16.5 following tamoxifen treatment at E8.5

palatal shelves fail to meet at midline ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 in 40% of embryos the palatal shelves have elevated but fail to grow to the midline

• however, in maxillary explant cultures shelves elevate and make medial contact at a similar rate to controls

cleft secondary palate ( J:278485 )

• at E16.5 in 36% of embryos following tamoxifen treatment at E8.5

abnormal palatal shelf elevation ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 only 33% of mutant embryos have both shelves elevated compared to 82% of controls

• following tamoxifen treatment at E8.5 at E14.5 palatal shelves appear to be obstructed by the arched tongue at the posterior end of the shelves

abnormal tongue muscle morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 tongue muscles lack apparent attachment to the hyoid primordium

abnormal tongue position ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 the tongue is arched to the posterior rather than relatively flat as in controls

decreased tongue size ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 tongue volume is slightly reduced compared to controls

• however, no defects in intrinsic muscle morphology are seen

growth/size/body

decreased palatine bone horizontal plate size ( J:278485 )

• feathery medial growth is lacking and ossified palatine bones do not approach the midline in 50% of embryos at E16.5 following tamoxifen treatment at E8.5

palatal shelves fail to meet at midline ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 in 40% of embryos the palatal shelves have elevated but fail to grow to the midline

• however, in maxillary explant cultures shelves elevate and make medial contact at a similar rate to controls

cleft secondary palate ( J:278485 )

• at E16.5 in 36% of embryos following tamoxifen treatment at E8.5

abnormal palatal shelf elevation ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 only 33% of mutant embryos have both shelves elevated compared to 82% of controls

• following tamoxifen treatment at E8.5 at E14.5 palatal shelves appear to be obstructed by the arched tongue at the posterior end of the shelves

abnormal tongue muscle morphology ( J:278485 )

• following tamoxifen treatment at E8.5 at E16.5 tongue muscles lack apparent attachment to the hyoid primordium

abnormal tongue position ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 the tongue is arched to the posterior rather than relatively flat as in controls

decreased tongue size ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5 tongue volume is slightly reduced compared to controls

• however, no defects in intrinsic muscle morphology are seen

Allelic Composition	Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi}
Genetic Background	involves: 129S4/SvJae * C57BL/6N * FVB/NJ

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj} mutation (3 available); any Gt(ROSA)26Sor mutation (942 available)
Rdh10^{tm1c(KOMP)Wtsi} mutation (0 available); any Rdh10 mutation (20 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal spontaneous fetal mouth movement ( J:278485 )

• following tamoxifen treatment at E8.5 at E14.5, head movements are not accompanied by detectable mouth opening or tongue movement unlike in controls

Allelic Composition	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Amh-cre)8815Reb/0 Tg(RARE-Hspa1b/lacZ)12Jrt/0 Tg(Stra8-icre)1Reb/0
Genetic Background	involves: C57BL/6 * C57BL/6N * CD-1 * FVB/N * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rdh10^{tm1c(KOMP)Wtsi} mutation (0 available); any Rdh10 mutation (20 available)
Tg(Amh-cre)8815Reb mutation (2 available)
Tg(RARE-Hspa1b/lacZ)12Jrt mutation (2 available)
Tg(Stra8-icre)1Reb mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

small testis ( J:193281 )

abnormal male reproductive system physiology ( J:193281 )

• lack of retinoic acid

endocrine/exocrine glands

small testis ( J:193281 )

Allelic Composition	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Stra8-icre)1Reb/0
Genetic Background	involves: C57BL/6 * C57BL/6N * FVB/NJ * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rdh10^{tm1c(KOMP)Wtsi} mutation (0 available); any Rdh10 mutation (20 available)
Tg(Stra8-icre)1Reb mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

reproductive system phenotype ( J:193281 )

N	• testes weight and morphology are indistinguishable from controls at 2 and 3 weeks of age

Allelic Composition	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Amh-cre)8815Reb/0
Genetic Background	involves: C57BL/6 * C57BL/6N * FVB/N * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rdh10^{tm1c(KOMP)Wtsi} mutation (0 available); any Rdh10 mutation (20 available)
Tg(Amh-cre)8815Reb mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

seminiferous tubule degeneration ( J:193281 )

• about 45% of the tubules are degenerated at 2 and 3 weeks of age

decreased testis weight ( J:193281 )

• at 2 and 3 weeks of age

abnormal male reproductive system physiology ( J:193281 )

• numerous degenerated germ cells are present in the testes

endocrine/exocrine glands

seminiferous tubule degeneration ( J:193281 )

• about 45% of the tubules are degenerated at 2 and 3 weeks of age

decreased testis weight ( J:193281 )

• at 2 and 3 weeks of age

Allelic Composition	Rdh10^{tm1c(KOMP)Wtsi}/Rdh10^{tm1c(KOMP)Wtsi} Tg(Amh-cre)8815Reb/0 Tg(Stra8-icre)1Reb/0
Genetic Background	involves: C57BL/6 * C57BL/6N * FVB/N * SJL

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

reproductive system

abnormal spermatogonia morphology ( J:193281 )

• block of differentiation of Aal spermatogonia into A1 spermatogonia at 2 and 3 weeks of age

abnormal seminiferous tubule morphology ( J:193281 )

• most tubules are devoid of meiotic cells at 2 and 3 weeks of age, retaining only undifferentiated spermatogonia-like cells and Sertoli cells

• however, by 9 weeks of age, tubules contain the expected spermatogonia, spermatocytes, and spermatids

seminiferous tubule degeneration ( J:193281 )

• over 85% of tubules are degenerated at 2 and 3 weeks of age

small testis ( J:193281 )

• at 2 and 3 weeks of age

decreased testis weight ( J:193281 )

• dramatically lower at 2 and 3 weeks of age compared to wild-type controls and homozygous mice carrying only one of the cre transgenes

abnormal spermatogenesis ( J:193281 )

• most tubules are devoid of meiotic cells at 2 and 3 weeks of age, retaining only undifferentiated spermatogonia-like cells and Sertoli cells

• treatment with retinoic acid enhances synchrony of spermatogenesis

• however, by 9 weeks of age, spermatogenesis is similar to controls

• in adults only 1 of 48 males shows spermatogenesis with an altered stage frequency

arrest of male meiosis ( J:193281 )

• fail to initiate meiosis at 2 and 3 weeks of age

abnormal male reproductive system physiology ( J:193281 )

• numerous degenerated germ cells are present in the testes at 2 and 3 weeks of age

reduced male fertility ( J:193281 )

• males under 7 weeks of age are infertile or subfertile

• however, mice over 9 weeks of age are fertile and produce litters similar in size to controls

endocrine/exocrine glands

abnormal seminiferous tubule morphology ( J:193281 )

• most tubules are devoid of meiotic cells at 2 and 3 weeks of age, retaining only undifferentiated spermatogonia-like cells and Sertoli cells

• however, by 9 weeks of age, tubules contain the expected spermatogonia, spermatocytes, and spermatids

seminiferous tubule degeneration ( J:193281 )

• over 85% of tubules are degenerated at 2 and 3 weeks of age

small testis ( J:193281 )

• at 2 and 3 weeks of age

decreased testis weight ( J:193281 )

• dramatically lower at 2 and 3 weeks of age compared to wild-type controls and homozygous mice carrying only one of the cre transgenes

cellular

abnormal spermatogonia morphology ( J:193281 )

• block of differentiation of Aal spermatogonia into A1 spermatogonia at 2 and 3 weeks of age

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23